Insider Trading & Ownership - SIEGALL CLAY B

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for SIEGALL CLAY B
Goto Prev, 0, 1
Common stock purchase or sale:
Transaction
Date		 Reported
DateTime		 Company Symbol Insider
Relationship		 Shares
Traded		 Average
Price		 Total
Amount		 Shares
Owned		 Filing
2020-08-18
Sale		 2020-08-20
6:26 pm		 SEATTLE GENETICS INC SGEN SIEGALL CLAY B
President and CEO		 27,060 $158.17 $4,280,053 719,261
(Direct)		 View
2020-08-10
Sale		 2020-08-13
06:04 am		 SEATTLE GENETICS INC SGEN SIEGALL CLAY B
President and CEO		 28,475 $156.74 $4,463,263 776,595
(Direct)		 View
2020-08-07
Sale		 2020-08-11
12:21 pm		 Ultragenyx Pharmaceutical Inc. RARE SIEGALL CLAY B
Director		 34,750 $85.37 $2,966,736 4,146
(Direct)		 View
2020-07-08
Sale		 2020-07-10
6:07 pm		 SEATTLE GENETICS INC SGEN SIEGALL CLAY B
President and CEO		 28,472 $175.08 $4,984,808 970,208
(Direct)		 View
2020-06-08
Sale		 2020-06-10
6:57 pm		 SEATTLE GENETICS INC SGEN SIEGALL CLAY B
President and CEO		 28,472 $148.77 $4,235,807 1,182,275
(Direct)		 View
2020-05-08
Sale		 2020-05-12
7:51 pm		 SEATTLE GENETICS INC SGEN SIEGALL CLAY B
President and CEO		 28,472 $161.01 $4,584,311 1,179,395
(Direct)		 View
2020-05-05
Sale		 2020-05-07
7:59 pm		 SEATTLE GENETICS INC SGEN SIEGALL CLAY B
President and CEO		 50,000 $165.65 $8,282,403 718,339
(Direct)		 View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date		 Reported
DateTime		 Exercisable
Expiration		 Company Symnbol Insider
Relationship		 Shares
Traded		 Conversion
Price		 Shares
Owned		 Filing
2020-08-17
Option Award		 2020-08-17
9:34 pm		 N/A
2030-08-17		 SEATTLE GENETICS INC SGEN SIEGALL CLAY B
President and CEO		 97,365 $0 815,704
(Direct)		 View
2020-08-10
Exercise		 2020-08-13
06:04 am		 N/A
N/A		 SEATTLE GENETICS INC SGEN SIEGALL CLAY B
President and CEO		 28,475 $12 776,595
(Direct)		 View
2020-08-10
Exercise		 2020-08-13
06:04 am		 N/A
2020-08-27		 SEATTLE GENETICS INC SGEN SIEGALL CLAY B
President and CEO		 28,475 $0 776,595
(Direct)		 View
2020-08-07
Exercise		 2020-08-11
12:21 pm		 N/A
N/A		 Ultragenyx Pharmaceutical Inc. RARE SIEGALL CLAY B
Director		 7,500 $40.37 4,146
(Direct)		 View
2020-08-07
Exercise		 2020-08-11
12:21 pm		 N/A
N/A		 Ultragenyx Pharmaceutical Inc. RARE SIEGALL CLAY B
Director		 17,500 $21 4,146
(Direct)		 View
2020-08-07
Exercise		 2020-08-11
12:21 pm		 N/A
2024-07-09		 Ultragenyx Pharmaceutical Inc. RARE SIEGALL CLAY B
Director		 25,000 $0 4,146
(Direct)		 View
2020-07-08
Exercise		 2020-07-10
6:07 pm		 N/A
N/A		 SEATTLE GENETICS INC SGEN SIEGALL CLAY B
President and CEO		 28,072 $12 970,208
(Direct)		 View
2020-07-08
Exercise		 2020-07-10
6:07 pm		 N/A
2020-08-27		 SEATTLE GENETICS INC SGEN SIEGALL CLAY B
President and CEO		 28,472 $0 970,208
(Direct)		 View
2020-06-26
Option Award		 2020-06-30
1:14 pm		 N/A
2030-06-26		 Ultragenyx Pharmaceutical Inc. RARE SIEGALL CLAY B
Director		 6,800 $0 16,550
(Direct)		 View
2020-06-08
Exercise		 2020-06-10
6:57 pm		 N/A
N/A		 SEATTLE GENETICS INC SGEN SIEGALL CLAY B
President and CEO		 28,472 $12 1,182,275
(Direct)		 View
2020-06-08
Exercise		 2020-06-10
6:57 pm		 N/A
2020-08-27		 SEATTLE GENETICS INC SGEN SIEGALL CLAY B
President and CEO		 28,472 $0 1,182,275
(Direct)		 View
2020-05-08
Exercise		 2020-05-12
7:51 pm		 N/A
N/A		 SEATTLE GENETICS INC SGEN SIEGALL CLAY B
President and CEO		 28,472 $12 1,179,395
(Direct)		 View
2020-05-08
Exercise		 2020-05-12
7:51 pm		 N/A
2020-08-27		 SEATTLE GENETICS INC SGEN SIEGALL CLAY B
President and CEO		 28,472 $0 1,179,395
(Direct)		 View
Goto Prev, 0, 1